EVI-1 oncogene expression predicts survival in chronic-phase CML patients resistant to imatinib treated with second-generation tyrosine kinase inhibitors (Q42882348)
Jump to navigation
Jump to search
scientific article published on 20 September 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | EVI-1 oncogene expression predicts survival in chronic-phase CML patients resistant to imatinib treated with second-generation tyrosine kinase inhibitors |
scientific article published on 20 September 2010 |
Statements
1 reference
EVI-1 oncogene expression predicts survival in chronic-phase CML patients resistant to imatinib treated with second-generation tyrosine kinase inhibitors (English)
1 reference
Mustafa Daghistani
1 reference
David Marin
1 reference
Jamshid Sorouri Khorashad
1 reference
Lihui Wang
1 reference
Christos Paliompeis
1 reference
Dragana Milojkovic
1 reference
Valeria A De Melo
1 reference
John M Goldman
1 reference
Jane F Apperley
1 reference
Richard E Clark
1 reference
Letizia Foroni
1 reference
Alistair G Reid
1 reference
20 September 2010
1 reference
1 reference
116
1 reference
26
1 reference
6014-6017
1 reference
Identifiers
1 reference
1 reference